Canadian Retina Society (CRS) Position Statement on Intravitreal Injections and the Management of Retinal Diseases during the COVID-19 Crisis
The Executive of the CRS has reviewed recommendations from local, national and international Medical and Ophthalmology groups regarding the management of patients and the risks to health care workers during this COVID crisis. The CRS provides the following commentary. These comments and recommendations are based on the “conditions on the ground” that exist today at the time of this writing.
Submissions for the Innovation in Retina Research Award being offered by COS with the support of Bayer Inc. are now being accepted. Residents or fellows enrolled in a Canadian clinical training program are encouraged to apply!
Can Ophthal Society's Twitter via Twitter Web Client
Redirecting to a Third-Party Website
You are now temporarily leaving the Practice Resource Centre. Clicking the button below will open a third-party website in a new browser tab. The website you are being redirected to is published by a third party and as such, its content is not under the control of the COS.